Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation.
Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation.
复制标题
DOI：
10.1155/2020/7234625
复制
发表时间：
2020
影响因子：
2.9
通讯作者：
Vargovich AM
中科院分区：
文献类型：
--
作者：
Nauser JW;Nelson CI;Gross RT;Vargovich AM
疼痛是一种复杂的多维体验，但通常被测量为一维体验。本研究旨在分别评估疼痛的感觉和情感成分，并确定其与重要疼痛相关结局的关系，特别是在阿巴拉契亚接受治疗的慢性疼痛患者中阿片类药物滥用风险和情绪失调方面。212名到多学科疼痛中心就诊的患者完成了情绪调节困难量表（DERS-18）、疼痛患者筛选和阿片类药物评估-修订版（SOAPP-R）和简短麦吉尔疼痛问卷（SF-MPQ）。疼痛感觉与情绪失调无关（r = 0.06，p = 0.57），与阿片类药物滥用风险弱相关（r = 0.182，p < 0.05）。相反，疼痛的情感体验与情绪失调中度相关（r = 0.217，p < 0.05），与阿片类药物滥用风险高度相关（r = 0.37，p < 0.01）。此外，情绪失调预测阿片类药物滥用风险的差异高于疼痛的情感和感觉体验（B = 0.693，p < 0.001）。研究结果表明，具有强烈情感体验与疼痛感觉体验以及情绪调节挑战的患者可能需要更全面的干预来解决这些潜在因素，以降低滥用阿片类药物的风险。
Pain is a complex, multidimensional experience but often is measured as a unidimensional experience. This study aimed to separately assess the sensory and affective components of pain and identify their relations to important pain-related outcomes, particularly in terms of opioid misuse risk and emotion dysregulation among patients with chronic pain receiving treatment in Appalachia. Two hundred and twelve patients presenting to a multidisciplinary pain center completed the Difficulties in Emotion Regulation Scale (DERS-18), Screener and Opioid Assessment for Patients with Pain—Revised (SOAPP-R), and short-form McGill Pain Questionnaire (SF-MPQ). The sensory experience of pain was unrelated to emotion dysregulation (r = 0.06, p = 0.57) and weakly related to opioid misuse risk (r = 0.182, p < 0.05). In contrast, the affective experience of pain was moderately related to emotion dysregulation (r = 0.217, p < 0.05) and strongly related to opioid misuse risk (r = 0.37, p < 0.01). In addition, emotion dysregulation predicted variance in opioid misuse risk above and beyond the affective and sensory experiences of pain ((b = 0.693, p < 0.001). The results suggest patients with a strong affective experience versus sensory experience of pain and challenges with emotion regulation may require a more comprehensive intervention to address these underlying components in order to reduce their risk of misusing opioid medications.
登录
查看更多内容
影响因子：
7.4
作者：
Connelly, Mark;Keefe, Francis J.;Waters, Sandra
通讯作者：
Waters, Sandra
影响因子：
4.4
作者：
Lutz, Julie;Gross, Richard T.;Vargovich, Alison M.
通讯作者：
Vargovich, Alison M.
影响因子：
4
作者：
Fillingim, Roger B.;Loeser, John D.;Baron, Ralf;Edwards, Robert R.
通讯作者：
Edwards, Robert R.
影响因子：
4
作者：
Ruiz-Aranda, Desiree;Martin Salguero, Jose;Fernandez-Berrocal, Pablo
通讯作者：
Fernandez-Berrocal, Pablo
影响因子：
1.5
作者：
Ferguson, Christopher J.
通讯作者：
Ferguson, Christopher J.